These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11485026)
1. Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. Beger M; Butz K; Denk C; Williams T; Hurst HC; Hoppe-Seyler F J Mol Med (Berl); 2001 Jun; 79(5-6):314-20. PubMed ID: 11485026 [TBL] [Abstract][Full Text] [Related]
2. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
3. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. Hoppe-Seyler F; Butz K Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181 [TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. Peto M; Tolle-Ersü I; Kreysch HG; Klock G J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475 [TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Prusty BK; Das BC Int J Cancer; 2005 Mar; 113(6):951-60. PubMed ID: 15514944 [TBL] [Abstract][Full Text] [Related]
7. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers. Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197 [TBL] [Abstract][Full Text] [Related]
9. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
10. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Bosher JM; Totty NF; Hsuan JJ; Williams T; Hurst HC Oncogene; 1996 Oct; 13(8):1701-7. PubMed ID: 8895516 [TBL] [Abstract][Full Text] [Related]
11. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955 [TBL] [Abstract][Full Text] [Related]
12. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells. Lee K; Lee AY; Kwon YK; Kwon H Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000 [TBL] [Abstract][Full Text] [Related]
13. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293 [TBL] [Abstract][Full Text] [Related]
14. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a. Yukawa K; Butz K; Yasui T; Kikutani H; Hoppe-Seyler F J Virol; 1996 Jan; 70(1):10-6. PubMed ID: 8523512 [TBL] [Abstract][Full Text] [Related]
15. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer. Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK Virol J; 2016 Apr; 13():60. PubMed ID: 27044426 [TBL] [Abstract][Full Text] [Related]
16. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1. Mori S; Takeuchi T; Ishii Y; Kukimoto I J Virol; 2020 May; 94(10):. PubMed ID: 32132238 [TBL] [Abstract][Full Text] [Related]
17. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. von Knebel Doeberitz M; Bauknecht T; Bartsch D; zur Hausen H Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1411-5. PubMed ID: 1847520 [TBL] [Abstract][Full Text] [Related]
18. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
19. Cellular control of human papillomavirus oncogene transcription. Hoppe-Seyler F; Butz K Mol Carcinog; 1994 Jul; 10(3):134-41. PubMed ID: 8043195 [TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]